ICPerMed, an international consortium on personalised medicine bringing together more than 40 European and international partners including ANR, has analysed the needs of stakeholders in the field over recent years, thus identifying 5 main challenges and levers of action for the implementation of personalised medicine. These are detailed in a Vision Paper published in 2019.
On the basis of this strategic document, the ICPerMed “Personalised medicine - From vision to practice” conference will be structured around 5 sessions during which speakers will present courses of action for:
A session will also be dedicated to lessons learned from the Covid-19 pandemic and the contribution of personalised medicine in the fight against infectious diseases. Furthermore, ICPerMed will feature and honour best practices in personalised medicine research through the ICPerMed Recognition 2020, aiming to recognise, encourage, promote and disseminate outstanding examples.
The conference will bring together world-renowned researchers, experts in ELSA (ethical, legal and social aspects), health economists, patients and representatives from industry, regulatory authorities, and members of ICPerMed, including representatives of ministries, research funding agencies and policy makers.
The French National Research Agency (ANR) is a member of the ICPerMed consortium alongside the Ministry of Higher Education, Research and Innovation. It is also involved in the CSA ICPerMed Secretariat (2016-2021), in the CSA EU-Africa PerMed aimed at the integration of African countries in ICPerMed discussions, and in the ERA-NET ERA PerMed. In the context of these partnerships, it participates in discussions on the international coordination of research in the field, finances transnational projects and encourages interdisciplinary collaborations for the implementation of personalised medicine.
The International Consortium of Personalised Medicine (ICPerMed) is a platform created in November 2016 which brings together more than 40 European and international partners representing ministries, funding agencies and the European Commission. The goal of ICPerMed is to stimulate personalised medicine by strengthening the coordination and alignment of research activities. ICPerMed website